{"id":"W2236030964","doi":"10.1176/appi.ajp.2015.15050648","title":"Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial","year":2016,"lang":"en","type":"article","venue":"American Journal of Psychiatry","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":97,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Aging; Canadian Institutes of Health Research; Avid Radiopharmaceuticals; Genentech; National Institutes of Health; Lundbeck Canada; National Football League Players Association; Grifols; Servier; Eisai; Astellas Pharma; Pfizer; Biogen; Centre for Addiction and Mental Health Foundation; Fondation Brain Canada; Centre for Addiction and Mental Health; University of Pennsylvania; AstraZeneca; International Parkinson and Movement Disorder Society; GlaxoSmithKline; CHDI Foundation; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Michael J. Fox Foundation for Parkinson's Research; Teva Pharmaceutical Industries; H. Lundbeck A/S; U.S. Department of Veterans Affairs","keywords":"Citalopram; Placebo; Randomized controlled trial; Medicine; Internal medicine; Alzheimer's disease; Psychology; Psychiatry; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01584683,0.002227121,0.005313757,0.0006786185,0.0007702701,0.002000532,0.001292083,0.003379406,0.005111324],"category_scores_gemma":[0.02319597,0.001012454,0.006956891,0.0007654473,0.00168028,0.001533689,0.0009650656,0.003292183,0.0004388294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0011242,"about_ca_system_score_gemma":0.001888318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000792131,"about_ca_topic_score_gemma":0.001254065,"domain_scores_codex":[0.9826937,0.01399691,0.001118661,0.001069096,0.0006353623,0.0004862494],"domain_scores_gemma":[0.9822564,0.0109197,0.004038856,0.001257103,0.0005693747,0.0009585232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9876181,0.001050116,0.001667285,0.0005193634,0.004445801,0.00003100354,0.00002962365,0.0002047942,0.0002895156,0.00008051559,0.0001910085,0.003872731],"study_design_scores_gemma":[0.967294,0.02399555,0.003180769,0.00007527604,0.004020791,0.0000323736,0.00002074204,0.0006078792,0.0001462165,0.0003082376,0.0002967185,0.00002153197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9698391,0.01514148,0.002142055,0.001976355,0.001209839,0.006998861,0.0009935313,0.0001049612,0.001593814],"genre_scores_gemma":[0.9903955,0.001672039,0.001736409,0.0007408481,0.000792941,0.003549054,0.0004752977,0.0000153141,0.0006227267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01584683,"threshold_uncertainty_score":0.08380705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05810174455522275,"score_gpt":0.4370109048808895,"score_spread":0.3789091603256667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}